Brian T. Crum - Feb 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, General Counsel & Secr.
Signature
/s/ Brian T. Crum
Stock symbol
LXRX
Transactions as of
Feb 28, 2024
Transactions value $
-$67,082
Form type
4
Date filed
2/29/2024, 04:27 PM
Previous filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +8.75K +6.49% 144K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +26.1K +18.18% 170K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +33.5K +19.72% 203K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Tax liability -$67.1K -25.6K -12.61% $2.62 177K Feb 28, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -8.75K -100% 0 Feb 28, 2024 Common Stock 8.75K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -26.1K -50% 26.1K Feb 28, 2024 Common Stock 26.1K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -33.5K -33.33% 66.9K Feb 28, 2024 Common Stock 33.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.